SHH UK Logo

Long COVID: a clinical update

Review

Category

Share

The Lancet published an article (31/07/24) which provides a comprehensive overview of the current state of knowledge and challenges surrounding Long Covid, also known as post-COVID-19 condition. The article found that Long Covid, defined as symptoms persisting for 3 months or more after acute COVID-19, affects multiple organ systems and poses a significant burden on individuals, healthcare systems, and economies. Despite extensive research, clinicians face challenges in evaluating and managing Long Covid due to conflicting definitions, multiple pathophysiological mechanisms, lack of a universal biomarker, and evolving nature of the condition.

The article identifies several priority areas for future Long Covid research, including genetic and epigenetic studies, biomarker development, next-generation clinical trials, and optimizing rehabilitation protocols and health services. Vaccine research is emphasized, particularly investigating protein-based vaccines for protection against reinfection and potential Long Covid exacerbation. The authors stress the importance of bridging the gap between biological mechanisms and clinical management through targeted research to address what has been described as the “mass disabling event” of Long Covid .

The full article can be read here. You can see one of the author’s twitter thread about the article here.

    Comments are closed

    More insights

    Tell us about your fundraising

    Your Details

    SHH-UK is committed to protecting your data, you can read more about how we do this via our privacy policy.

    By filling out the fundraising enquiry form with your personal information you consent to the terms and conditions of our Privacy Policy.

    If you wish to change the way you are kept informed about our work here at Cavell please get in touch with us at info@shh-uk.org

    Communcation preferences

    Our Newsletter

    Please enter your details to sign up for our newsletter below.